MasterPharm Recalls Tadalafil 18 mg Capsules Due to Processing Control Deficiencies
MasterPharm LLC is recalling Tadalafil 18 mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a theoretical risk related to processing controls rather than a confirmed high-risk pathogen or structural defect, fitting the criteria for a moderate severity score.
Plain-English summary
MasterPharm LLC is voluntarily recalling Tadalafil 18 mg capsules, 90 capsules per bottle, distributed nationwide in the United States. The recall is being conducted due to a lack of processing controls, which means there is a lack of assurance that the product conforms to its specifications.
The affected product is identified by the following lot codes and expiration dates: 01-23-2020:33@15 (BUD 7/21/2020), 02-07-2020:48@3 (BUD 8/5/2020), and 02-26-2020:09@15 (BUD 8/24/2020). The total quantity involved in this recall is 900 capsules.
Consumers who have purchased this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for further instructions or a refund. The company is located at 115-02 Liberty Ave, Richmond Hill, NY 11419.
The recalled product
- Product
- Tadalafil 18 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 900
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 01-23-2020:33@15
- BUD 7/21/2020 02-07-2020:48@3
- BUD 8/5/2020 02-26-2020:09@15
- BUD 8/24/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · processing defect
See all →- SevereWayne Farms Recalls Undercooked Ready-to-Eat Chicken Breast Products
USDA FSIS · 2023-12-07
- HighUndercooked Ready-to-Eat Stuffed Chicken Product Subject to Public Health Alert
USDA FSIS · 2023-02-03
- SevereWayne Farms Recalls Undercooked Ready-to-Eat Chicken Breast Fillets
USDA FSIS · 2022-04-29
- ModerateMasterPharm Recalls Sildenafil Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Similar recalls
- SevereMasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
FDA (Drugs) · 2020-05-20
- HighTadalafil Tablets Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-05-03
- ModerateTadalafil Tablets 20 mg recalled due to manufacturing deviations
FDA (Drugs) · 2023-05-03
- ModeratePrescription Tadalafil tablets recalled for manufacturing process deviations
FDA (Drugs) · 2023-04-12
- ModerateMedical Park Pharmacy Recalls Tadalafil 6 mg Capsules for Labeling Errors
FDA (Drugs) · 2020-02-05
- HighTadalafil tablets recalled for manufacturing quality control deviations
FDA (Drugs) · 2023-03-08